These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25868070)

  • 1. T76. Baclofen as a pharmacotherapy for the treatment of concurrent alcohol and nicotine dependence: a double-blind, placebo-controlled, randomized trial.
    Farokhnia M; Edwards SM; Bollinger J; Amodio J; Zywiak WH; Tidey JW; Swift RM; Kenna GA; Leggio L
    Neuropsychopharmacology; 2015 May; 40(6):1560. PubMed ID: 25868070
    [No Abstract]   [Full Text] [Related]  

  • 2. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
    J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
    Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
    Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
    J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
    Morley KC; Leung S; Baillie A; Haber PS
    Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence.
    Heinzerling KG; Shoptaw S; Peck JA; Yang X; Liu J; Roll J; Ling W
    Drug Alcohol Depend; 2006 Dec; 85(3):177-84. PubMed ID: 16740370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
    Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial.
    Xu D; Qu C; Meng H; Ren J; Zhu Y; Min Z; Kong Y
    BJU Int; 2007 Sep; 100(3):588-92. PubMed ID: 17511770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus.
    Westerberg BD; Roberson JB; Stach BA
    Am J Otol; 1996 Nov; 17(6):896-903. PubMed ID: 8915419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
    Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.
    Grant JE; Odlaug BL; Chamberlain SR; Potenza MN; Schreiber LR; Donahue CB; Kim SW
    J Clin Psychiatry; 2014 Jan; 75(1):39-45. PubMed ID: 24345329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study).
    Higuchi S;
    J Clin Psychiatry; 2015 Feb; 76(2):181-8. PubMed ID: 25742205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Vonghia L; Mirijello A; Abenavoli L; D'Angelo C; Caputo F; Zambon A; Haber PS; Gasbarrini G
    Lancet; 2007 Dec; 370(9603):1915-22. PubMed ID: 18068515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study.
    Corwin RL; Boan J; Peters KF; Ulbrecht JS
    Behav Pharmacol; 2012 Sep; 23(5-6):616-25. PubMed ID: 22854310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan.
    Huang MC; Chen CH; Yu JM; Chen CC
    Addict Biol; 2005 Sep; 10(3):289-92. PubMed ID: 16109592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.